Skip Navigation LinksHome > January 2011 - Volume 6 - Issue 1 > Targeted cytotoxic therapy: adapting a rapidly progressing a...
Current Opinion in HIV & AIDS:
doi: 10.1097/COH.0b013e3283412515
HIV reservoirs: from pathogenesis to drug development: Edited by Robert F. Siliciano and Janet D. Siliciano

Targeted cytotoxic therapy: adapting a rapidly progressing anticancer paradigm for depletion of persistent HIV-infected cell reservoirs

Berger, Edward A

Collapse Box

Abstract

Purpose of review: HIV-infected cells persisting in the face of highly active antiretroviral therapy are arguably the greatest hurdle to eradication of the virus from the body. Complementary strategies aimed at selective killing of infected cells are described.

Recent findings: Pioneered by research in the cancer field, various approaches are under development for selective killing of HIV-infected cells. These include targeted cytotoxic proteins, adoptive cell therapy, cytocidal virotherapy, and targeted nonbiological drug carriers.

Summary: These developmental efforts may provide a critical complement to antiretroviral therapy in efforts to achieve HIV eradication, or a ‘functional cure’ whereby therapy can be stopped without viral rebound.

© 2011 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.